0.6753
Precedente Chiudi:
$0.6819
Aprire:
$0.7037
Volume 24 ore:
124.81K
Relative Volume:
0.52
Capitalizzazione di mercato:
$5.50M
Reddito:
$11.67M
Utile/perdita netta:
$-2.79M
Rapporto P/E:
-1.7851
EPS:
-0.3783
Flusso di cassa netto:
$-2.55M
1 W Prestazione:
-16.06%
1M Prestazione:
-39.16%
6M Prestazione:
-71.86%
1 anno Prestazione:
-77.71%
Nexgel Inc Stock (NXGL) Company Profile
Nome
Nexgel Inc
Settore
Industria
Telefono
215 702-8550
Indirizzo
2150 CABOT BLVD WEST,, LANGHORNE
Compare NXGL vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
NXGL
Nexgel Inc
|
0.6753 | 5.55M | 11.67M | -2.79M | -2.55M | -0.3783 |
|
ISRG
Intuitive Surgical Inc
|
469.98 | 166.92B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
158.27 | 45.02B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.26 | 36.68B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
42.67 | 34.63B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
226.31 | 32.97B | 5.40B | 1.49B | 1.78B | 10.12 |
Nexgel Inc Borsa (NXGL) Ultime notizie
NEXGEL signs agreement to acquire regenerative biomaterial portfolio - MSN
NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st - marketscreener.com
NEXGEL sets March 31 earnings release, 4:30 p.m. ET call - Stock Titan
NEXGEL to pay $15 million for Celularity regenerative biomaterial portfolio - MSN
Oxford Industries Earnings: What To Look For From OXM - Barchart.com
NEXGEL secures $1.8 million financing for potential acquisition - MSN
NEXGEL (NXGLW) Expected to Announce Earnings on Monday - Defense World
Nexgel Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
NEXGEL to Pay $15 Million for Celularity Regenerative Biomaterial Portfolio - MyChesCo
Portfolio Recap: Can NEXGEL Inc stock double in the next year2026 Key Lessons & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Market Pulse: Whats the beta of NEXGEL Inc stock2026 Levels & Safe Swing Trade Setups - baoquankhu1.vn
Market Outlook: Can NEXGEL Inc stock double in the next year2026 Momentum Check & Advanced Technical Analysis Signals - baoquankhu1.vn
NEXGEL Signs Agreement to Acquire Regenerative Biomaterial Portfolio - MyChesCo
NexGel (NXGL) Expected to Announce Earnings on Monday - Defense World
NexGel to license, acquire regenerative biomaterial products - Investing.com Nigeria
UmzugsPreisChecker Announces 50,000 Moves Milestone - Barchart.com
NexGel, IncCommon Stock (NQ: NXGL - The Chronicle-Journal
NEXGEL discloses $15M upfront payment for Celularity portfolio By Investing.com - Investing.com Canada
NXGL Stock: NEXGEL Signs Deal to Triple Revenue and Turn Profitable With Acquisition of Six Commercial-Stage Regenerative Biomaterial Products - Barchart
NEXGEL discloses $15M upfront payment for Celularity portfolio - Investing.com
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities - The Manila Times
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products - marketscreener.com
NEXGEL Announces Consideration Terms of Agreement to - GlobeNewswire
Inside Celularity’s bet on NEXGEL to shake up wound care biomaterials - Stock Titan
Asymmetry Point LP holds 610,000 shares of NexGel (NXGL) reporting 7.49% stake - Stock Titan
Biotechnology company Celularity Inc. (NASDAQ: CELU) recently reaffirmed its strategic commercialization partnership with NEXGEL, INC. (NASDAQ: NXGL). - Bitget
NexGel to license, acquire regenerative biomaterial products By Investing.com - Investing.com Canada
NexGel Acquires Celularity Regenerative Biomaterials in Transformative Deal - TipRanks
Celularity Licenses Biomaterials Portfolio to NexGel Partner - TipRanks
NexGel to Acquire Celularity Biomaterials Assets and Exclusive License in Deal Up to $35 Million - TradingView
Deal to triple NEXGEL (NASDAQ: NXGL) revenue and add profits - Stock Titan
Celularity Sells and Licenses Biomaterials Portfolio to NexGel in Deal Worth Up to $35 Million - TradingView
NEXGEL, Inc. to Acquire Regenerative Biomaterial Portfolio from Celularity, Anticipating Tripled Revenue and Immediate Profitability - Quiver Quantitative
NEXGEL Signs Definitive Agreement to License and Acquire - GlobeNewswire
EXCLUSIVE: NexGel To Acquire Regenerative Biomaterial Portfolio From Celularity, Expects To Triple Revenue - Benzinga
2 Reasons to Like CALM (and 1 Not So Much) - Barchart.com
Inspire Medical Systems (INSP): Buy, Sell, or Hold Post Q4 Earnings? - Barchart.com
NEXGEL CEO Adam Levy to Join 6th Annual Semco Capital Networking Event in Chicago - MSN
Is NEXGEL Inc. Equity Warrant stock resilient to inflationWeekly Trade Summary & Weekly High Return Opportunities - Naître et grandir
NEXGEL Expands Partnership With STADA, Secures $1 Million to Fuel New Product Launches - MSN
NexGel, Inc. Stock Plummets to New 52-Week Low of $1.04 - Markets Mojo
Stocks in play: Quarterhill Inc. - Barchart
Head to Head Survey: Pacific Biosciences of California (NASDAQ:PACB) and NexGel (NASDAQ:NXGL) - Defense World
NexGel, Inc. Hits New 52-Week Low at $1.05 Amidst Decline - Markets Mojo
NexGel, Inc. Stock Plummets to New 52-Week Low of $1.09 - Markets Mojo
NXGL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
NXGL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
NexGel, Inc. Hits New 52-Week Low at USD 1.15 Amid Decline - Markets Mojo
NexGel, Inc. Hits New 52-Week Low at $1.11 Amidst Declining Performance - Markets Mojo
NXGLW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Earnings Report: Is NEXGEL Inc currently under institutional pressureRate Cut & Weekly Watchlist of Top Performers - baoquankhu1.vn
Nexgel Inc Azioni (NXGL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):